China Pharma Holdings Inc (CPHI) - Financial and Strategic SWOT Analysis Review
China Pharma Holdings Inc (CPHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
China Pharma Holdings Inc (China Pharma) focuses on developing, manufacturing and marketing of prescription drugs, OTC and nutritional products. The company offers western and traditional Chinese medicines in different therapeutic areas including central nervous system (CNS), cardiovascular, cerebrovascular, anti-viral, digestive diseases, infectious diseases, food supplements and others. China Pharma offers products in the various dosage forms including lyophilized injectables, granules, capsules, tablets, injectables and oral fluids. It markets products in various provinces through sales offices across China. China Pharma is headquartered in Haikou, Hainan, China.
China Pharma Holdings Inc Key Recent Developments
Nov 12,2021: China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results
Nov 12,2021: China Pharma Holding Q3 EPS $(0.02), Same YoY, Sales $2.00M Down From $2.40M YoY
Sep 15,2021: China Pharma Holdings: Departure of directors or certain o?cers; election of directors; appointment of certain o?cers; compensatory arrangements of certain o?cers
Aug 13,2021: China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results
Jun 09,2021: China Pharma to launch highly purified NMN+PQQ product
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
China Pharma Holdings Inc (China Pharma) focuses on developing, manufacturing and marketing of prescription drugs, OTC and nutritional products. The company offers western and traditional Chinese medicines in different therapeutic areas including central nervous system (CNS), cardiovascular, cerebrovascular, anti-viral, digestive diseases, infectious diseases, food supplements and others. China Pharma offers products in the various dosage forms including lyophilized injectables, granules, capsules, tablets, injectables and oral fluids. It markets products in various provinces through sales offices across China. China Pharma is headquartered in Haikou, Hainan, China.
China Pharma Holdings Inc Key Recent Developments
Nov 12,2021: China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results
Nov 12,2021: China Pharma Holding Q3 EPS $(0.02), Same YoY, Sales $2.00M Down From $2.40M YoY
Sep 15,2021: China Pharma Holdings: Departure of directors or certain o?cers; election of directors; appointment of certain o?cers; compensatory arrangements of certain o?cers
Aug 13,2021: China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results
Jun 09,2021: China Pharma to launch highly purified NMN+PQQ product
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
China Pharma Holdings Inc - Key Facts
China Pharma Holdings Inc - Key Employees
China Pharma Holdings Inc - Key Employee Biographies
China Pharma Holdings Inc - Major Products and Services
China Pharma Holdings Inc - History
China Pharma Holdings Inc - Company Statement
China Pharma Holdings Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
China Pharma Holdings Inc - Business Description
Product Category: Anti-Viro/ Infection & Respiratory
Overview
Performance
Product Category: CNS Cerebral & Cardio Vascular
Overview
Performance
Product Category: Digestive Diseases
Overview
Performance
Product Category: Others
Overview
Performance
China Pharma Holdings Inc - Corporate Strategy
China Pharma Holdings Inc - SWOT Analysis
SWOT Analysis - Overview
China Pharma Holdings Inc - Strengths
China Pharma Holdings Inc - Weaknesses
China Pharma Holdings Inc - Opportunities
China Pharma Holdings Inc - Threats
China Pharma Holdings Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
China Pharma Holdings Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Nov 12, 2021: China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results
Sep 15, 2021: China Pharma Holdings: Departure of directors or certain o?cers; election of directors; appointment of certain o?cers; compensatory arrangements of certain o?cers
Aug 13, 2021: China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results
Jun 09, 2021: China Pharma to launch highly purified NMN+PQQ product
May 14, 2021: China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue
Mar 26, 2021: China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results
Nov 13, 2020: China Pharma Holdings reports third quarter 2020 financial results
Sep 21, 2020: China Pharmaceutical Holdings has obtained multiple certifications for its masks
Aug 14, 2020: China Pharma Holdings reports second quarter 2020 financial results
May 15, 2020: China Pharma Holdings reports first quarter 2020 financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
China Pharma Holdings Inc - Key Facts
China Pharma Holdings Inc - Key Employees
China Pharma Holdings Inc - Key Employee Biographies
China Pharma Holdings Inc - Major Products and Services
China Pharma Holdings Inc - History
China Pharma Holdings Inc - Company Statement
China Pharma Holdings Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
China Pharma Holdings Inc - Business Description
Product Category: Anti-Viro/ Infection & Respiratory
Overview
Performance
Product Category: CNS Cerebral & Cardio Vascular
Overview
Performance
Product Category: Digestive Diseases
Overview
Performance
Product Category: Others
Overview
Performance
China Pharma Holdings Inc - Corporate Strategy
China Pharma Holdings Inc - SWOT Analysis
SWOT Analysis - Overview
China Pharma Holdings Inc - Strengths
China Pharma Holdings Inc - Weaknesses
China Pharma Holdings Inc - Opportunities
China Pharma Holdings Inc - Threats
China Pharma Holdings Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
China Pharma Holdings Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Nov 12, 2021: China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results
Sep 15, 2021: China Pharma Holdings: Departure of directors or certain o?cers; election of directors; appointment of certain o?cers; compensatory arrangements of certain o?cers
Aug 13, 2021: China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results
Jun 09, 2021: China Pharma to launch highly purified NMN+PQQ product
May 14, 2021: China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue
Mar 26, 2021: China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results
Nov 13, 2020: China Pharma Holdings reports third quarter 2020 financial results
Sep 21, 2020: China Pharmaceutical Holdings has obtained multiple certifications for its masks
Aug 14, 2020: China Pharma Holdings reports second quarter 2020 financial results
May 15, 2020: China Pharma Holdings reports first quarter 2020 financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
China Pharma Holdings Inc, Key Facts
China Pharma Holdings Inc, Key Employees
China Pharma Holdings Inc, Key Employee Biographies
China Pharma Holdings Inc, Major Products and Services
China Pharma Holdings Inc, History
China Pharma Holdings Inc, Subsidiaries
China Pharma Holdings Inc, Key Competitors
China Pharma Holdings Inc, Ratios based on current share price
China Pharma Holdings Inc, Annual Ratios
China Pharma Holdings Inc, Annual Ratios (Cont...1)
China Pharma Holdings Inc, Annual Ratios (Cont...2)
China Pharma Holdings Inc, Interim Ratios
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
China Pharma Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
China Pharma Holdings Inc, Key Facts
China Pharma Holdings Inc, Key Employees
China Pharma Holdings Inc, Key Employee Biographies
China Pharma Holdings Inc, Major Products and Services
China Pharma Holdings Inc, History
China Pharma Holdings Inc, Subsidiaries
China Pharma Holdings Inc, Key Competitors
China Pharma Holdings Inc, Ratios based on current share price
China Pharma Holdings Inc, Annual Ratios
China Pharma Holdings Inc, Annual Ratios (Cont...1)
China Pharma Holdings Inc, Annual Ratios (Cont...2)
China Pharma Holdings Inc, Interim Ratios
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
China Pharma Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
China Pharma Holdings Inc, Performance Chart (2016 - 2020)
China Pharma Holdings Inc, Ratio Charts
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
China Pharma Holdings Inc, Performance Chart (2016 - 2020)
China Pharma Holdings Inc, Ratio Charts
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
China Pharma Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021